Works matching AU KIM, MIKYUNG


Results: 85
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active‐controlled, randomized, double‐blind study with open‐label extension (the EVERGREEN study).

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1527, doi. 10.1111/dom.14061
    By:
    • Kim, Gyuri;
    • Lim, Soo;
    • Kwon, Hyuk‐Sang;
    • Park, Ie B.;
    • Ahn, Kyu J.;
    • Park, Cheol‐Young;
    • Kwon, Su K.;
    • Kim, Hye S.;
    • Park, Seok W.;
    • Kim, Sin G.;
    • Moon, Min K.;
    • Kim, Eun S.;
    • Chung, Choon H.;
    • Park, Kang S.;
    • Kim, Mikyung;
    • Chung, Dong J.;
    • Lee, Chang B.;
    • Kim, Tae H.;
    • Lee, Moon‐Kyu
    Publication type:
    Article
    19
    20
    21
    23

    4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels.

    Published in:
    Psychopharmacology, 2020, v. 237, n. 3, p. 757, doi. 10.1007/s00213-019-05412-y
    By:
    • Abiero, Arvie;
    • Botanas, Chrislean Jun;
    • Custodio, Raly James;
    • Sayson, Leandro Val;
    • Kim, Mikyung;
    • Lee, Hyun Jun;
    • Kim, Hee Jin;
    • Lee, Kun Won;
    • Jeong, Youngdo;
    • Seo, Joung-Wook;
    • Ryu, In Soo;
    • Lee, Yong Sup;
    • Cheong, Jae Hoon
    Publication type:
    Article
    24

    The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT<sub>2</sub> receptors

    Published in:
    Psychopharmacology, 2019, v. 236, n. 7, p. 2201, doi. 10.1007/s00213-019-05219-x
    By:
    • Sayson, Leandro Val;
    • Botanas, Chrislean Jun;
    • Custodio, Raly James Perez;
    • Abiero, Arvie;
    • Kim, Mikyung;
    • Lee, Hyun Jun;
    • Kim, Hee Jin;
    • Yoo, Sung Yeun;
    • Lee, Kun Won;
    • Ryu, Hye Won;
    • Acharya, Srijan;
    • Kim, Kyeong-Man;
    • Lee, Yong Sup;
    • Cheong, Jae Hoon
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Silencing CDCA8 Suppresses Hepatocellular Carcinoma Growth and Stemness via Restoration of ATF3 Tumor Suppressor and Inactivation of AKT/β–Catenin Signaling.

    Published in:
    Cancers, 2021, v. 13, n. 5, p. 1055, doi. 10.3390/cancers13051055
    By:
    • Jeon, Taewon;
    • Ko, Min Ji;
    • Seo, Yu-Ri;
    • Jung, Soo-Jung;
    • Seo, Daekwan;
    • Park, So-Young;
    • Park, Keon Uk;
    • Kim, Kwang Seok;
    • Kim, Mikyung;
    • Seo, Ji Hae;
    • Park, In-Chul;
    • Kim, Min-Ji;
    • Bae, Jae-Hoon;
    • Song, Dae-Kyu;
    • Cho, Chi Heum;
    • Lee, Jae-Ho;
    • Lee, Yun-Han;
    • Visconti, Roberta
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50